Issue of Shares and Total Voting Rights

15 September 2020

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

Issue of Shares and Total Voting Rights

DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, announces that 42,800,000 Deferred Consideration Shares have been issued to Springer Nature in respect of the acquisition of InfoChem GMBH in March 2019.

Application has been made to the London Stock Exchange for the Deferred Consideration Shares to be admitted to trading on AIM. It is expected that Admission will take place at 8:00am on 21 September 2020.

Following the Admission of the Deferred Consideration Shares the Company will have 921,897,281 Ordinary Shares in issue. Therefore, the total voting rights in DeepMatter will be 921,897,281. This figure may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

For more information, please contact:

About DeepMatter Group plc 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors. 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster. 

Visit: www.deepmatter.io and follow @deepmattergroup